JP2020521790A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020521790A5 JP2020521790A5 JP2019566112A JP2019566112A JP2020521790A5 JP 2020521790 A5 JP2020521790 A5 JP 2020521790A5 JP 2019566112 A JP2019566112 A JP 2019566112A JP 2019566112 A JP2019566112 A JP 2019566112A JP 2020521790 A5 JP2020521790 A5 JP 2020521790A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- activator
- effective amount
- composition
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012190 activator Substances 0.000 claims 14
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 claims 3
- 229960001967 tacrolimus Drugs 0.000 claims 3
- QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 claims 3
- 241000239290 Araneae Species 0.000 claims 2
- 239000004593 Epoxy Substances 0.000 claims 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 2
- 230000002745 absorbent Effects 0.000 claims 2
- 239000002250 absorbent Substances 0.000 claims 2
- 239000011230 binding agent Substances 0.000 claims 2
- 239000000835 fiber Substances 0.000 claims 2
- 229910021485 fumed silica Inorganic materials 0.000 claims 2
- 239000000463 material Substances 0.000 claims 2
- 239000005995 Aluminium silicate Substances 0.000 claims 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims 1
- 206010013774 Dry eye Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 235000012211 aluminium silicate Nutrition 0.000 claims 1
- 239000004067 bulking agent Substances 0.000 claims 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims 1
- 238000013268 sustained release Methods 0.000 claims 1
- 239000012730 sustained-release form Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023077694A JP7682226B2 (ja) | 2017-05-30 | 2023-05-10 | ドライアイ症候群を治療するための抗生物質マクロライドを送達する組成物および方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762512682P | 2017-05-30 | 2017-05-30 | |
| US62/512,682 | 2017-05-30 | ||
| PCT/IB2018/000693 WO2018220444A2 (en) | 2017-05-30 | 2018-05-30 | Compositions and methods for treating dry eye syndrome delivering antibiotic macrolide |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023077694A Division JP7682226B2 (ja) | 2017-05-30 | 2023-05-10 | ドライアイ症候群を治療するための抗生物質マクロライドを送達する組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020521790A JP2020521790A (ja) | 2020-07-27 |
| JP2020521790A5 true JP2020521790A5 (https=) | 2021-07-26 |
| JP7278969B2 JP7278969B2 (ja) | 2023-05-22 |
Family
ID=64456159
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019566112A Active JP7278969B2 (ja) | 2017-05-30 | 2018-05-30 | ドライアイ症候群を治療するための抗生物質マクロライドを送達する組成物および方法 |
| JP2023077694A Active JP7682226B2 (ja) | 2017-05-30 | 2023-05-10 | ドライアイ症候群を治療するための抗生物質マクロライドを送達する組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023077694A Active JP7682226B2 (ja) | 2017-05-30 | 2023-05-10 | ドライアイ症候群を治療するための抗生物質マクロライドを送達する組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20200147055A1 (https=) |
| EP (1) | EP3630042A4 (https=) |
| JP (2) | JP7278969B2 (https=) |
| KR (1) | KR20200069261A (https=) |
| CN (1) | CN111278401B (https=) |
| CA (1) | CA3065474A1 (https=) |
| WO (1) | WO2018220444A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022096931A2 (en) * | 2020-11-09 | 2022-05-12 | Eximore Ltd. | Punctal plugs containing micelle-encapsulated ophthalmic pharmaceuticals and methods for making thereof |
| WO2024069230A2 (en) * | 2022-09-29 | 2024-04-04 | Eximore Ltd. | Ophthalmic compositions and methods for sustained drug release |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5443505A (en) * | 1993-11-15 | 1995-08-22 | Oculex Pharmaceuticals, Inc. | Biocompatible ocular implants |
| AU777915B2 (en) * | 1999-04-30 | 2004-11-04 | Sucampo Ag | Use of macrolide compounds for the treatment of dry eye |
| US20030018044A1 (en) * | 2000-02-18 | 2003-01-23 | Peyman Gholam A. | Treatment of ocular disease |
| US6489335B2 (en) * | 2000-02-18 | 2002-12-03 | Gholam A. Peyman | Treatment of ocular disease |
| CA2539324A1 (en) * | 2003-09-18 | 2005-03-31 | Macusight, Inc. | Transscleral delivery |
| US7087237B2 (en) * | 2003-09-19 | 2006-08-08 | Advanced Ocular Systems Limited | Ocular solutions |
| CN101437478A (zh) * | 2004-10-04 | 2009-05-20 | Qlt美国有限公司 | 聚合送递制剂的眼部送递 |
| DE602004017477D1 (de) * | 2004-11-09 | 2008-12-11 | Novagali Pharma Sa | Öl-in-Wasser-Emulsion mit niedriger Konzentration des kationischen Mittels und positivem Zetapotential |
| JP4974903B2 (ja) * | 2005-02-09 | 2012-07-11 | 参天製薬株式会社 | 疾患または状態を処置するための液体処方物 |
| EP2004172B1 (en) * | 2006-03-31 | 2019-03-13 | Mati Therapeutics Inc. | Drug delivery structures and compositions for nasolacrimal system |
| UY30883A1 (es) * | 2007-01-31 | 2008-05-31 | Alcon Res | Tapones punctales y metodos de liberacion de agentes terapeuticos |
| EP2320972B1 (en) * | 2008-05-08 | 2020-07-01 | MiniPumps, LLC | Implantable drug-delivery devices |
| EP2376019A1 (en) * | 2008-12-19 | 2011-10-19 | QLT, Inc. | Substance delivering punctum implants and methods |
| AU2011235002B2 (en) * | 2010-03-31 | 2016-08-11 | Ocuject, Llc | Device and method for intraocular drug delivery |
| CA2798084A1 (en) * | 2010-05-17 | 2011-11-24 | Aerie Pharmaceuticals, Inc. | Drug delivery devices for delivery of ocular therapeutic agents |
| ES2727203T3 (es) * | 2011-08-29 | 2019-10-14 | Mati Therapeutics Inc | Administración por liberación sostenida de agentes activos para tratar glaucoma e hipertensión ocular |
| EP2916827B1 (en) * | 2012-11-08 | 2020-06-10 | Clearside Biomedical Inc. | Methods for the treatment of ocular disease in human subjects |
| MX364310B (es) * | 2013-11-05 | 2019-04-22 | Gustavo A Garcia Sanchez | Método para preparar una formulación inmunosupresora. |
| WO2016083891A1 (en) * | 2014-11-25 | 2016-06-02 | Eyal Sheetrit | Compositions and methods for delivering a bio-active agent or bio-active agents |
-
2018
- 2018-05-30 WO PCT/IB2018/000693 patent/WO2018220444A2/en not_active Ceased
- 2018-05-30 KR KR1020197038288A patent/KR20200069261A/ko not_active Ceased
- 2018-05-30 EP EP18809051.8A patent/EP3630042A4/en not_active Withdrawn
- 2018-05-30 US US16/617,173 patent/US20200147055A1/en not_active Abandoned
- 2018-05-30 CN CN201880050530.3A patent/CN111278401B/zh not_active Expired - Fee Related
- 2018-05-30 JP JP2019566112A patent/JP7278969B2/ja active Active
- 2018-05-30 CA CA3065474A patent/CA3065474A1/en active Pending
-
2023
- 2023-05-10 JP JP2023077694A patent/JP7682226B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012505836A5 (https=) | ||
| JP2015143836A5 (https=) | ||
| JP2013541975A5 (https=) | ||
| JP2007523049A5 (https=) | ||
| JP2020521790A5 (https=) | ||
| JP2008044945A5 (https=) | ||
| JP2017101084A5 (https=) | ||
| JP2006511373A5 (https=) | ||
| JP2015504081A5 (https=) | ||
| JP2015007131A5 (https=) | ||
| JP2015516427A5 (https=) | ||
| JP2017535592A5 (https=) | ||
| JP2013544125A5 (https=) | ||
| JP2016505023A5 (https=) | ||
| RU2011152105A (ru) | Составы таблеток 3-цианохинолина и их применение | |
| JP2016530291A5 (https=) | ||
| JP2022132411A5 (https=) | ||
| JP2017518873A5 (https=) | ||
| JP2013537037A5 (https=) | ||
| JP2019210561A5 (https=) | ||
| JP2019104717A5 (https=) | ||
| JP2018515567A5 (https=) | ||
| JP2016515550A5 (https=) | ||
| EA201170784A1 (ru) | Гранулы тамсулозина для фиксированной комбинации | |
| JP2006506536A5 (https=) |